WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops novel anticancer therapeutics using its antibody-drug conjugate (ADC) technology, today announced that it has been named one of The Boston Globe’s Top Places to Work. The Company has received this recognition for the second consecutive year and in three of the last four years.
Help employers find you! Check out all the jobs and post your resume.
